The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Provexis and Unicorn Mineral post chunkier losses

Fri, 30th Dec 2022 15:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Galileo Resources PLC - exploration and development mining company focused on US and Africa - Posts pretax profit of GBP1.2 million in the six months that ended September 30, swinging from a loss of GBP552,4933 a year before. Says this includes a fair value adjustment on non-current asset held for sale of GBP2.4 million for Galileo's interest in the Glenover Phosphate project. No revenue is recorded.

----------

Unicorn Mineral Resources PLC - explorer for copper, lead, zinc and silver in Irish midlands - Loss for the six months to September 30 widens to EUR139,737 from EUR39,236 a year before. Says this is due to a rise in professional fees to EUR129,000 from EUR30,902 the prior year as the company applies to be listed on the London Stock Exchange, as well as EUR10,737 in administrative expenses. Shares floated at 10 pence. The stock closed at 15p on Friday in London, up 50% from the initial public offering price.

----------

Hellenic Dynamics PLC - London-based medicinal cannabis cultivator and supplier - Pretax loss narrows to GBP279,667 in the six months that ended September 30 from GBP427,783 a year before. Records no revenue, which is unchanged from the prior year. Says it did not trade during the period, as "significant work" was undertaken to progress the acquisition of Hellenic Dynamic SA which was completed this month. The only transactions in the period were costs of operating Hellenic and transaction costs of progressing the acquisition, which amounted to GBP279,667 in total.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Posts pretax loss of GBP173,742 in the six months that ended September 30, widening from GBP145,189 a year before. Revenue declines by 15% to GBP179,369 from GBP211,195 the prior year. Says this is due to short-term lockdowns and other Covid-19 disruptions in the Asia Pacific region. Looking ahead, says Fruitflow is "well-placed to play an important role in the Chinese cardiovascular health market under the permitted health function claim legislation".

----------

Harland & Wolff Group Holdings PLC - London-based offshore construction company - Lowers 2022 revenue expectations to between GBP29 million and GBP31 million, from the previous guidance of GBP65 million and GBP75 million. Says it was unable to undertake certain work streams in the M55 Regeneration Programme by the Ministry of Defence on behalf of the Lithuanian Defence Materiel Agency, during the fourth quarter of 2022, due to a lack of material availability and specialist original equipment manufacturers' parts amid global supply chain issues. Clients in the cruise and ferry market are to either defer their contracts into 2023 or reduce the scope of works. Says the loss of revenues on this account for the fourth quarter of 2022 will be between GBP8 million and GBP10 million.

----------

By Jaskeet Briah, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.